Buy Sun Pharmaceutical Industries, target Rs 585: Shrikant Chouhan
Buy Sun Pharmaceutical Industries at a price target of Rs 585 and a stop loss at Rs 553 from entry point.
By ETMarkets.com |
Shrikant Chouhan of Kotak Securities Limited has a buy call on Sun Pharmaceutical Industries with a target price of Rs 585.
The current market price of Sun Pharmaceutical Industries is Rs 563.20.
Time period given by the analyst is intraday when Sun Pharmaceutical Industries price can reach defined target.
Shrikant Chouhan recommended to keep a stop loss at Rs 553.
Sun Pharmaceutical Industries, incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 1,35,129.03 Crore) operating in Pharmaceuticals and health care sector.
Sun Pharmaceutical Industries key Products/Revenue Segments include Pharmaceuticals which contributed Rs 7,523.79 Crore to Sales Value (96.37 per cent of Total Sales) and Other Operating Revenue which contributed Rs 282.91 Crore to Sales Value (3.62 per cent of Total Sales)for the year ending 31-Mar-2017.
The company’s top management includes Mr.Ashwin Dani, Mr.Dilip S Shanghvi, Mr.Hasmukh S Shah, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Keki M Mistry, Mr.S Mohanchand Dadha, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Ms.Rekha Sethi.
Company has Deloitte Haskins & Sells as its auditors.
As on 30-09-2017, the company has a total of 2,399,308,086 shares outstanding.
The current market price of Sun Pharmaceutical Industries is Rs 563.20.
Time period given by the analyst is intraday when Sun Pharmaceutical Industries price can reach defined target.
Shrikant Chouhan recommended to keep a stop loss at Rs 553.
Sun Pharmaceutical Industries, incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 1,35,129.03 Crore) operating in Pharmaceuticals and health care sector.
Sun Pharmaceutical Industries key Products/Revenue Segments include Pharmaceuticals which contributed Rs 7,523.79 Crore to Sales Value (96.37 per cent of Total Sales) and Other Operating Revenue which contributed Rs 282.91 Crore to Sales Value (3.62 per cent of Total Sales)for the year ending 31-Mar-2017.
ADVERTISEMENT
The company’s top management includes Mr.Ashwin Dani, Mr.Dilip S Shanghvi, Mr.Hasmukh S Shah, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Keki M Mistry, Mr.S Mohanchand Dadha, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Ms.Rekha Sethi.
Company has Deloitte Haskins & Sells as its auditors.
As on 30-09-2017, the company has a total of 2,399,308,086 shares outstanding.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
